Antiserum-mediated demyelination: relationship between remyelination and functional recovery
- PMID: 7406444
- DOI: 10.1002/ana.410080103
Antiserum-mediated demyelination: relationship between remyelination and functional recovery
Abstract
A focal demyelinative lesion of peripheral nerve was produced by intraneural injection of either antiserum from rabbits with experimental allergic neuritis or experimental allergic encephalomyelitis or antiserum to galactocerebroside. We studied the relationship between clinical and electrophysiological recovery from this lesion and the morphological pattern of remyelination. Foot muscles on the the injected side weakened within an hour of injection and remained paralyzed for 7 days; strength gradually returned to normal by 16 days after injection. Electrophysiological conduction block, apparent within a few hours of injection, persisted for about 7 days. At 8 days we detected dispersed, very low amplitude muscle action potentials with long latency. Morphologically, demyelinated axons were surrounded by Schwann cells at 7 days after injection, but compacted myelin was not present. After 8 days, remyelinating axons became surrounded by thickening compacted myelin. The time of onset of remyelination and the rate of remyelination up to 14 days following the injection were independent of axon size. The onset of clinical and electrophysiological recovery from the lesion corresponded to the appearance of 2 to 8 myelin lamellae around each remyelinating axon. At 37 days after injection, when conduction velocities had returned to preinjection values, myelin thickness of remyelinating fibers had increased to approximately one-third that of control nerves.
Similar articles
-
Immune-mediated demyelination--immunopathological basis for electrophysiological changes.Electroencephalogr Clin Neurophysiol Suppl. 1982;36:56-69. Electroencephalogr Clin Neurophysiol Suppl. 1982. PMID: 6962042
-
Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve.Ann Neurol. 1982 May;11(5):469-77. doi: 10.1002/ana.410110506. Ann Neurol. 1982. PMID: 6285800
-
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum.Lab Invest. 1978 Nov;39(5):449-62. Lab Invest. 1978. PMID: 732272
-
Demyelination in spinal cord injury.J Neurol Sci. 1989 Jun;91(1-2):1-14. doi: 10.1016/0022-510x(89)90072-5. J Neurol Sci. 1989. PMID: 2664092 Review.
-
Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders.Eye (Lond). 1994;8 ( Pt 2):224-37. doi: 10.1038/eye.1994.51. Eye (Lond). 1994. PMID: 7958027 Review.
Cited by
-
Treatment of chronic inflammatory demyelinating polyneuropathy.Ital J Neurol Sci. 1998 Oct;19(5):261-9. doi: 10.1007/BF00713851. Ital J Neurol Sci. 1998. PMID: 10933445 Review.
-
Guillain-Barré syndrome: clinical and immunological aspects.Springer Semin Immunopathol. 1995;17(1):29-42. doi: 10.1007/BF00194098. Springer Semin Immunopathol. 1995. PMID: 7482224 Review.
-
Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy.Microorganisms. 2022 Oct 28;10(11):2139. doi: 10.3390/microorganisms10112139. Microorganisms. 2022. PMID: 36363731 Free PMC article. Review.
-
Conduction in segmentally demyelinated mammalian central axons.J Neurosci. 1997 Oct 1;17(19):7267-77. doi: 10.1523/JNEUROSCI.17-19-07267.1997. J Neurosci. 1997. PMID: 9295373 Free PMC article.
-
Electrophysiology of Guillain-Barré syndrome in Bangladesh: A prospective study of 312 patients.Clin Neurophysiol Pract. 2021 Apr 22;6:155-163. doi: 10.1016/j.cnp.2021.03.007. eCollection 2021. Clin Neurophysiol Pract. 2021. PMID: 35112034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources